European Patent Office approves instagraft patent
S2Medical AB (publ) has today received the response from the European Patent Office that they intend to grant patent protection for the Company’s instagraft technology within around forty European countries. The instagraft technology is a surgical instrument that can be used for minimally invasive skin transplantation and is intended to move this procedure from specialist units out to the primary healthcare units. This would result in a higher number of patients suffering from chronic ulcers getting access to skin transplantation and thereby being able to heal their wounds. ”The